Neuroethics Journal Club: Sexual Fantasies and Gender/Sex
In May of 2013, The New York Times Magazine published an article discussing the ongoing clinical trials of a unique new drug that caught the interest of Emory University neuroscience graduate student Mallory Bowers. The drug, dubbed “Lybrido”, was being tested for its ability to improve sexual desire in women. However, Lybrido is not just a female Viagra-like formulation. That is apparently one part of it but the other, perhaps more surprising part, is the pill’s testosterone coating that is designed to melt away immediately in the mouth. To better understand how testosterone (T) could modulate female desire, and to discuss the neuroethical implications of pharmaceutically targeting it, Ms. Bowers chose a recent paper in the Journal of Sex Research by Goldey et al. entitled “Sexual Fantasies and Gender/Sex: A Multimethod Approach with Quantitative Content Analysis and Hormonal Responses” for the second Neuroethics Journal Club of the year. In the present study, Sari ...